It’s time for a reality check about certain ‘weight loss’ drugs, and here’s why
Much hype surrounds drugs called GLP-1 agonists but they are intended for diabetes patients and people who are obese, not those who just want to lose a few pounds
Ozempic
Chief obesity clinician Prof Donal O’Shea ‘shocked’ at prevalence of black market ‘skinny jabs’
RTÉ Investigates programme to be aired on Monday examines illegitimate sales of weight loss drugs, despite some being labelled as ‘not for human use’
Lilly’s Zepbound tops Novo Nordisk’s Wegovy for weight loss in head-to-head trial
Companies competing for leadership in fast-growing market where supply continues to be an issue
Sharp increase in number of illegal weight loss drugs seized
HPRA warns of risks of illegal, counterfeit versions of drugs such as Ozempic and Wegovy, saying they pose ‘significant risk’
Trump nominates vaccine sceptic Robert F Kennedy jnr to run US health department
Appointment would put Kennedy, who sowed doubts about Covid-19 vaccines, in charge of a department with a $1.8 trillion budget
Weight-loss drugs show promise in tackling opioid and alcohol abuse
Academic notes while Ozempic might prevent overdoses, weight loss drug may not actually reduce or end substance use
Britain’s anti-obesity jab plan is the stuff of sci-fi
Drastic action is considered essential, but this is part of a wider strategy that represents a looming calamity for Stormont
‘We can be violent to ourselves. Brutal’: Demi Moore on body image, reinvention and her most shocking role yet
Actor (61) plays a has-been celebrity who is tempted by a youth serum in hyperreal film The Substance
As a cardiologist, here is what I tell my patients about Ozempic
Using such medications to lose excess fat that risks your health is no more of a moral failing than using a blood pressure medication to lower high blood pressure that increases your risk of stroke
The truth about the ‘Ozempic baby boom’
The new generation of weight loss medications have revolutionised the treatment of obesity. But reports of an unexpected side effect - surprise pregnancies - have led to questions about why this is happening
Novo Nordisk drops Dublin factory plan
Seen & Heard: Inheritance tax reduction, Press Up stake and Spar sale
Large increase in number of fake weight-loss drugs seized by watchdog in 2024
Officials warned consumers of risks from falsified versions of Ozempic and Wegovy
Nestlé develops fast food range aimed at people taking weight loss drugs like Ozempic
The new brand, Vital Pursuit, is set to hit supermarket shelves in the US this October
Ozempic and Wegovy maker Novo Nordisk set to build large manufacturing facility in Dublin
News of new factory comes after Danish group announced in December the purchase of drug manufacturing plant in Athlone in order to keep up with demand for weight-loss drugs
Ozempic maker Novo Nordisk buys Irish drug manufacturing plant in €85m deal
Danish weight loss and diabetes specialist is looking to develop a tablet form of its blockbuster obesity treatments
Ozempic drug-maker pushed Government to oppose EU pharma reforms
Proposals would lower time period a company has protection over research behind drugs they develop
David Norris’s life in politics: ‘People had the idea that gay people are monstrous. I wanted them to see the human’
The senator on living alone, destigmatising homosexuality, and stepping down from politics
Weight-loss drugs hurt snack company shares
Concerns about weight-loss drugs hurting sales are ‘overblown’ say Citi analysts but investors are worried
Regulator warned GPs over Ozempic advertising breaches
Correspondence between health officials details 'high level of concern' about obesity drug shortages
The Truth About the ‘Skinny’ Jab: Are weight-loss injections a magic wand or potential health disaster?
Television: Presenter Anna Richardson explores how drugs like Ozempic and Wegovy work and the potential side effects
Obesity drugs make Novo Nordisk Europe’s biggest company
Company boosted by trial results showing weight loss drug also cuts risk of heart attack by 20%
Pharma giant behind Ozempic paid doctors thousands in speaking fees and expenses
Novo Nordisk profits surging due to huge demand for obesity drugs Ozempic and Wegovy
Novo Nordisk says obesity pill leads to 15% weight loss
Danish drugmaker pushing for US and EU approval but has struggled to meet demand for its Ozempic and Wegovy drugs
Ozempic: We may be on the brink of solving a decades-old crisis with a single medicine
It is easy to assume the world is getting progressively worse. And then along comes a huge leap forward in science or medicine to challenge the misery
Ireland on the cusp of obesity treatment revolution but high cost of drugs causing disquiet
Medications offer hope to patients with severe weight problems but will also be demanded by many for aesthetic reasons
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices